Geoffrey Parker

Geoffrey Parker

DirectoratPERRIGO Co· In proxies 2023–2025

Geoffrey Parker sits on 11 public boards.

Boards1

  • PERRIGO CoDirector · 8 yr on the boardIndependentAudit—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. PERRIGO CoPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  2. Allogene TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years
  3. 2009 – 2022: ChemoCentryx (NASDAQ: CCXI)Public company
    • Director? – PresentNo stock prices for these years
  4. 2016 – 2017: Sunesis Pharmaceuticals (NASDAQ: SNSS) NotablePublic company
    • Director? – PresentNo stock prices for these years
  5. 2016 – 2019: Genomic Health (NASDAQ: GHDX)Public company
    • Director? – PresentNo stock prices for these years
  6. 2021 - March 2Public company
    • Director? – PresentNo stock prices for these years
  7. 2021 – March 2024: Better Therapeutics (NASDAQ: BTTX)Public company
    • Director? – PresentNo stock prices for these years
  8. Better TherapeuticsPublic company
    • Director? – PresentNo stock prices for these years
  9. Genomic HealthPublic company
    • Director? – PresentNo stock prices for these years
  10. Other Public Company DirectorshipsPublic company
    • Director? – PresentNo stock prices for these years
  11. Sunesis PharmaceuticalsPublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?